Complete Dose Comparison: When Results Begin
At What Dose Does Wegovy Start Working Compared to Mounjaro's Initial Response
The question of at what dose does Wegovy start working versus Mounjaro requires understanding their distinct mechanisms and dosing schedules. Wegovy (semaglutide) is a GLP-1 receptor agonist that begins at 0.25mg for weeks 1-4, designed primarily for dose tolerability rather than maximum efficacy. Patients often report reduced appetite and increased satiety within the first 2-3 weeks, though therapeutic weight management effects typically become more pronounced at 0.5mg and beyond. Mounjaro (tirzepatide) starts at a higher 2.5mg dose as a dual GIP and GLP-1 receptor agonist, with many patients experiencing appetite suppression effects from the initial dose.
The fundamental difference lies in their escalation philosophy: Wegovy's gradual 4-week intervals allow the body to adjust to semaglutide's effects, whilst Mounjaro's higher starting dose reflects tirzepatide's different tolerability profile. Clinical evidence suggests that at what dose does Wegovy start working depends on individual factors, but most patients notice meaningful appetite changes by the 0.5mg dose (weeks 5-8). Mounjaro patients may experience effects sooner due to the higher initial dose, though both medications require the full escalation schedule alongside a reduced-calorie diet and increased physical activity for optimal results.
Wegovy vs Mounjaro Pricing: Value at Every Dose Level
Understanding at what dose does Wegovy start working becomes more relevant when comparing costs across both medications' escalation schedules. Wegovy's 0.25mg starter dose costs £79.99 at EverydayMeds, progressing to £94.99 for 0.5mg, £99.99 for 1mg, £139.99 for 1.7mg, and £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles offer convenience with the Intro Duo (0.25mg & 0.5mg) at £169.99, covering your first 8 weeks of treatment. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 for their discount on these final prices.
Mounjaro pricing follows a different structure due to its 6-dose range from 2.5mg to 15mg, with costs typically higher per pen reflecting the dual GIP/GLP-1 mechanism. The question of at what dose does Wegovy start working becomes financially relevant as you'll spend approximately £174.98 on the first two doses before reaching more therapeutic levels. EverydayMeds stocks both medications through our GPhC-registered pharmacy (#9012878), allowing your prescriber to recommend the most suitable option based on your clinical assessment and budget considerations.
Clinical Evidence: When Wegovy and Mounjaro Doses Show Efficacy
Research into at what dose does Wegovy start working draws from the STEP clinical trial programme, particularly STEP 1 published by Wilding et al. in NEJM, 2021. Patients following the prescribed escalation schedule alongside lifestyle interventions achieved approximately 15% average weight loss at 68 weeks, with effects becoming measurable around weeks 8-12. The study demonstrates that whilst appetite changes may begin at 0.25mg, clinically significant weight management typically requires progression to at least 1mg.
Mounjaro's clinical evidence from the SURMOUNT trials shows efficacy beginning at the 2.5mg starting dose, though maximum benefits require escalation to higher doses over 20 weeks. The dual GIP/GLP-1 mechanism may provide earlier appetite suppression compared to semaglutide alone, though individual responses vary significantly. Both medications are prescription-only medicines requiring ongoing medical supervision to determine optimal dosing.
How Wegovy's Mechanism Determines Effective Dose Timing
Understanding at what dose does Wegovy start working requires knowledge of semaglutide's GLP-1 receptor agonist mechanism. The medication mimics your natural incretin hormone GLP-1, which signals satiety to your brain after meals and slows gastric emptying to prolong fullness. At the 0.25mg starting dose, these effects begin establishing but may not be potent enough for significant appetite suppression in all patients. The 0.5mg dose typically provides more noticeable appetite reduction, whilst 1mg and above deliver the therapeutic levels studied in clinical trials. This mechanism works alongside dietary changes and physical activity, not as a standalone solution for weight management.
EverydayMeds Ordering Process: From Assessment to Dose Delivery
Accessing either Wegovy or Mounjaro through EverydayMeds begins with our 3-minute online clinical assessment, designed to determine suitability for prescription weight management medication. Our qualified prescribers review your submission within 3 working days (or 24 hours with express service) to ensure appropriate dosing and safety considerations. Once approved, your chosen starting dose ships via next-day delivery in temperature-controlled packaging to maintain medication integrity. This process ensures you receive genuine prescription-only medicines from our GPhC-registered pharmacy (#9012878) rather than unregulated sources. Our clinical team provides ongoing support throughout your dose escalation journey, helping address any questions about effectiveness timing or side effect management.
Storage and Practical Considerations: Wegovy vs Mounjaro Advantages
The practical aspects of at what dose does Wegovy start working include storage requirements that differ from Mounjaro's specifications. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but can remain at room temperature below 30°C for up to 6 weeks once removed from refrigeration. Mounjaro has a shorter 21-day room temperature tolerance, making Wegovy more convenient for travel or varying storage conditions. Both medications use pre-filled injection pens (FlexTouch for Wegovy) with dose escalation occurring every 4 weeks, requiring careful scheduling to avoid treatment interruptions. The 6-week room temperature advantage of Wegovy can be particularly relevant for patients concerned about maintaining cold storage throughout their escalation schedule.
Dose Escalation Timing: Wegovy's Gradual Approach vs Mounjaro's Higher Start
The clinical rationale behind at what dose does Wegovy start working relates to its conservative escalation schedule compared to Mounjaro's approach. Wegovy's 4-week intervals at each dose allow patients to develop tolerance to common gastrointestinal effects before increasing the semaglutide level. This gradual approach means therapeutic effects may take 8-16 weeks to fully manifest, but typically results in better treatment adherence and fewer discontinuations due to side effects. Mounjaro's higher starting dose may provide earlier appetite suppression but requires careful monitoring for tolerability.
Both medications require the full prescribed escalation schedule - patients cannot skip doses or accelerate the timeline without medical supervision. Understanding at what dose does Wegovy start working helps set realistic expectations: initial doses focus on tolerance building, whilst later doses provide the therapeutic levels demonstrated in clinical trials. Your EverydayMeds prescriber can help adjust timing based on your individual response and tolerance profile.
Expert Support: Choosing Between Wegovy and Mounjaro Dosing
Determining at what dose does Wegovy start working for your specific situation requires professional medical guidance available through EverydayMeds' clinical team. Both medications are available from our GPhC-registered pharmacy, allowing your prescriber to recommend the most appropriate option based on your clinical assessment, medical history, and treatment goals. Our pharmacists can explain the practical differences between semaglutide's weekly injection schedule and how dose timing affects your daily routine. Whether you start with Wegovy's 0.25mg gentle introduction or Mounjaro's 2.5mg initial dose, our team provides ongoing support throughout your weight management journey. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and receive personalised guidance on which medication and dosing schedule may be most suitable for your needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
